We have established an in vivo model for genetic analysis of the inflammatory response by generating a transgenic zebrafish line that expresses GFP under the neutrophil-specific myeloperoxidase promoter. We show that inflammation is induced after transection of the tail of zebrafish larvae and that this inflammation subsequently resolves over a similar time course to mammalian systems. Quantitative data can be generated from this model by counting of fluorescent cells or by digital image analysis. In addition, we show that the resolution of experimentally induced inflammation can be inhibited by the addition of a pancaspase inhibitor, zVD.fmk, demonstrating that experimental manipulation of the resolution of inflammation is possible in this model. IntroductionNeutrophilic inflammation is essential for the maintenance of health and life, but failure to resolve the response in a timely manner can cause irreparable tissue damage because of the release of toxic granule contents of persisting neutrophils. 1 An understanding of the genetic basis of inflammation resolution would undoubtedly provide an important basis for the development of approaches to limiting neutrophil-mediated tissue injury. To facilitate such a genetic analysis, an animal model in which the cellular components of inflammation can be readily visualized in wild-type and genetically manipulated individuals is required.Zebrafish larvae are transparent, allowing excellent visualization of fluorescent proteins in cellular processes in vivo. Zebrafish neutrophils (heterophils) are identifiable from approximately 48 hours after fertilization, 2 and the innate immune system exists in isolation from any adaptive system, which does not arise until approximately 4 weeks after fertilization. 3 A range of tools is available for the genetic manipulation of the zebrafish, as are extensive genomics resources, including a draft sequence of the entire genome. We therefore selected this species as an ideal organism for the generation of a simplified, genetically tractable model using fluorescent neutrophils to track the inflammatory response. Here, we report the generation of a transgenic zebrafish line for use in such experiments and describe the onset and resolution of inflammation in this model. We show that inflammation proceeds with kinetics similar to those in mammalian systems and that experimental manipulation of inflammation in this system is achievable and quantifiable. Materials and methodsZebrafish were maintained according to standard protocols. 4 Reagents were from Sigma (Poole, United Kingdom) unless otherwise specified. zVD.fmk was from Bachem (Weil am Rhein, Germany). MPO::GFP lineBAC (zC91B8) was modified by the use of a red recombinase system in EL250 cells (gift of Dr Neal Copeland, National Cancer Institute, Frederick, MD). 5 EGFP with an SV40 polyadenylation site (Clontech, Palo Alto, CA) was inserted at the mpo (also called mpx) ATG start site. This BAC, linearized with PI-Sce1, was used to generate stable transgenic lines according to publis...
The transcription factor Sox10 is required for the specification, migration and survival of all nonectomesenchymal neural crest derivatives including melanophores. sox10-/- zebrafish lack expression of the transcription factor mitfa, which itself is required for melanophore development. We demonstrate that the zebrafish mitfa promoter has sox10 binding sites necessary for activity in vitro, consistent with studies using mammalian cell cultures that have shown that Sox10 directly regulates Mitf expression. In addition, we demonstrate that these sites are necessary for promoter activity in vivo. We show that reintroduction of mitfa expression in neural crest cells can rescue melanophore development in sox10-/- embryos. This rescue of melanophores in sox10-/- embryos is quantitatively indistinguishable from rescue in mitfa-/- embryos. These findings show that the essential function of sox10 in melanophore development is limited to transcriptional regulation of mitfa. We propose that the dominant melanophore phenotype in Waardenburg syndrome IV individuals with SOX10 mutations is likely to result from failure to activate MITF in the normal number of melanoblasts.
Components of the zebrafish GDNF receptor complex are expressed very early in the development of enteric nervous system precursors, and are already present as these cells begin to enter the gut and migrate caudally along its length. Both gfra1a and gfra1b as well as ret are expressed at this time, while gfra2 expression, the receptor component that binds the GDNF-related ligand neurturin, is not detected until the precursors have migrated along the gut. Gfra genes are also expressed in regions of the zebrafish brain and peripheral ganglia, expression domains conserved with other species. Enteric neurons are eliminated after injection with antisense morpholino oligonucleotides against ret or against both Gfra1 orthologs, but are not affected by antisense oligonucleotides against gfra2. Blocking GDNF signaling prevents migration of enteric neuron precursors, which remain positioned at the anterior end of the gut. Phenotypes induced by injection of antisense morpholinos against both Gfra orthologs can be rescued by introduction of mRNA for gfra1a or for gfra2, suggesting that GFRα1 and GFRα2 are functionally equivalent.
The zebrafish embryo develops a series of anatomically distinct slow twitch muscle fibres that characteristically express genes encoding lineage-specific isoforms of sarcomeric proteins such as MyHC and troponin. We show here that different subsets of these slow fibres express distinct members of a tandem array of slow MyHC genes. The first slow twitch muscle fibres to differentiate, which are specified by the activity of the transcription factor Prdm1 (also called Ubo or Blimp1) in response to Hedgehog (Hh) signalling, express the smyhc1 gene. Subsequently, secondary slow twitch fibres differentiate in most cases independently of Hh activity. We find that although some of these later-forming fibres also express smyhc1, others express smyhc2 or smyhc3. We show that the smyhc1-positive fibres express the ubo (prdm1) gene and adopt fast twitch fibre characteristics in the absence of Prdm1 activity, whereas those that do not express smyhc1 can differentiate independently of Prdm1 function. Conversely, some smyhc2-expressing fibres, although independent of Prdm1 function, require Hh activity to form. The adult trunk slow fibres express smyhc2 and smyhc3, but lack smyhc1 expression. The different slow fibres in the craniofacial muscles variously express smyhc1, smyhc2 and smyhc3, and all differentiate independently of Prdm1.
The zebrafish u‐boot (ubo) gene encodes the transcription factor Prdm1, which is essential for the specification of the primary slow‐twitch muscle fibres that derive from adaxial cells. Here, we show that Prdm1 functions by acting as a transcriptional repressor and that slow‐twitch‐specific muscle gene expression is activated by Prdm1‐mediated repression of the transcriptional repressor Sox6. Genes encoding fast‐specific isoforms of sarcomeric proteins are ectopically expressed in the adaxial cells of ubotp39 mutant embryos. By using chromatin immunoprecipitation, we show that these are direct targets of Prdm1. Thus, Prdm1 promotes slow‐twitch fibre differentiation by acting as a global repressor of fast‐fibre‐specific genes, as well as by abrogating the repression of slow‐fibre‐specific genes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.